Safety and efficacy of recombinant activated coagulation factor VII in congenital hemophilia with inhibitors in the home treatment setting: A review of clinical studies and registries-Reference-Cited by-同舟云学术

Safety and efficacy of recombinant activated coagulation factor VII in congenital hemophilia with inhibitors in the home treatment setting: A review of clinical studies and registries

Published:2017-07-19 Issue:9 Volume:92 Page:940-945
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Young Guy¹,Escobar Miguel A.²,Pipe Steven W.³,Cooper David L.⁴^ORCID

Affiliation:

1. Hemostasis and Thrombosis Center, Children's Hospital Los Angeles, University of Southern California Keck School of Medicine; Los Angeles California

2. University of Texas Health Science Center and the Gulf States Hemophilia and Thrombophilia Center; Houston Texas

3. Hemophilia and Coagulation Disorders Program; University of Michigan; Ann Arbor Michigan

4. Clinical, Medical and Regulatory Affairs; Novo Nordisk Inc; Plainsboro New Jersey

Funder

Novo Nordisk Inc., Plainsboro, New Jersey

Publisher

Wiley

Subject

Hematology

Reference47 articles.

1. Guidelines for the management of hemophilia;Srivastava;Haemophilia.,2013

2. Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors;Key;Thromb Haemost.,1998

3. Early treatment with recombinant factor VIIa results in greater efficacy with less product;Lusher;Eur J Haematol Suppl.,1998

4. Home-based factor infusion therapy and hospitalization for bleeding complications among males with haemophilia;Soucie;Haemophilia.,2001

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current status and future prospects of activated recombinant coagulation factor VIIa, NovoSeven®, in the treatment of haemophilia and rare bleeding disorders;Annals of Hematology;2023-06-30

2. Recent update on coagulation management and hemostatic therapies in liver transplantation;Minerva Anestesiologica;2018-09

3. Cyborgs, Robots and Society: Implications for the Future of Society from Human Enhancement with In-The-Body Technologies;Technologies;2018-05-19

4. Methodologies for data collection in congenital haemophilia with inhibitors (CHwI): critical assessment of the literature and lessons learned from recombinant factor VIIa;Haemophilia;2018-05-09

5. Living with an inhibitor: Results from the Study of Haemophilia Experiences, Results and Opportunities in Children and young adults with long-standing inhibitors (the SO-HEROIC study);The Journal of Haemophilia Practice;2018-05-01